135 related articles for article (PubMed ID: 12053067)
41. [Effect of hemodialysis on the level of serum digoxin-like substance and sodium-potassium pump activity in erythrocytes from patients with chronic renal failure].
Czarkowski M; Ignatowska-Switalska H; Jabłońska-Skwiecińska E; Drygieniec D; Wardyn K; Rojek-Trebicka J; Staniszewska K; Chodakowska J
Pol Arch Med Wewn; 1992 Jun; 87(6):325-31. PubMed ID: 1329041
[TBL] [Abstract][Full Text] [Related]
42. Erythrocyte Na,K pump in uremia. Acute correction of a transport defect by hemodialysis.
Izumo H; Izumo S; DeLuise M; Flier JS
J Clin Invest; 1984 Aug; 74(2):581-8. PubMed ID: 6086716
[TBL] [Abstract][Full Text] [Related]
43. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
44. Adenine metabolism in erythrocytes of patients with Duchenne muscular dystrophy.
Frass M; Toifl K; Leixnering W
Eur Neurol; 1983; 22(5):380-4. PubMed ID: 6628465
[TBL] [Abstract][Full Text] [Related]
45. Accumulation of vitamin E metabolites in the blood of renal failure patients.
Galli F; Floridi AG; Floridi A; Buoncristiani U
Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
[TBL] [Abstract][Full Text] [Related]
46. Changed purine nucleotide concentrations and enzyme activities in erythrocytes of haemodialysis patients undergoing erythropoietin therapy.
Siems W; Grune T; Hampl H; Wendel G; Gerber G; Riedel E
Eur J Clin Chem Clin Biochem; 1992 Aug; 30(8):455-60. PubMed ID: 1445958
[TBL] [Abstract][Full Text] [Related]
47. Erythrocyte nitric oxide metabolism in patients with chronic renal failure.
Durak I; Oztürk HS; Elgün S; Cimen MY; Yalçin S
Clin Nephrol; 2001 Jun; 55(6):460-4. PubMed ID: 11434357
[TBL] [Abstract][Full Text] [Related]
48. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
[TBL] [Abstract][Full Text] [Related]
49. Accumulation of scandium in plasma in patients with chronic renal failure.
Sánchez-González C; López-Chaves C; Rivas-García L; Galindo P; Gómez-Aracena J; Aranda P; Llopis J
ScientificWorldJournal; 2013; 2013():782745. PubMed ID: 24396309
[TBL] [Abstract][Full Text] [Related]
50. On a regulatory system of the adenine level in the plasma connected with red cell maturation and its effect on the adenine nucleotides of the circulating erythrocyte. Lack of relation between ATP-level and life span of the erythrocyte.
Syllm-Rapoport I; Jacobasch G; Prehn S; Rapoport S
Blood; 1969 Apr; 33(4):617-27. PubMed ID: 5776207
[No Abstract] [Full Text] [Related]
51. Effect of hemodialysis on plasma and erythrocyte phenylalanine levels in end-stage kidney patients.
St epniewski M; Smoleński O; Kopeć J; Kuźniewski M
Nephron; 1985; 39(3):189-93. PubMed ID: 3974781
[TBL] [Abstract][Full Text] [Related]
52. Alterations of serum reverse triiodothyronine and thyroxine kinetics in chronic renal failure: role of nutritional status, chronic illness, uremia, and hemodialysis.
Kaptein EM; Feinstein EI; Nicoloff JT; Massry SG
Kidney Int Suppl; 1983 Dec; 16():S180-6. PubMed ID: 6588250
[TBL] [Abstract][Full Text] [Related]
53. Influence of glucose in the dialysate on the activity of erythrocyte-glutathione-peroxidase and blood selenium concentration in hemodialyzed patients.
Bober J; Kwiatkowska E; Kedzierska K; Olszewska M; Gołebiewska E; Stachowska E; Kucharska E; Ciechanowski K; Chlubek D
Arch Med Res; 2007 Apr; 38(3):330-6. PubMed ID: 17350485
[TBL] [Abstract][Full Text] [Related]
54. The relationship between hematocrit and erythrocyte magnesium concentration in patients on regular hemodialysis.
Gonella M; Betti G; Buzzigoli G; Bartolini V
Nephron; 1979; 24(3):134-7. PubMed ID: 492423
[TBL] [Abstract][Full Text] [Related]
55. Mycophenolate mofetil treatment following renal transplantation decreases GTP concentrations in mononuclear leucocytes.
Jagodzinski P; Lizakowski S; Smolenski RT; Slominska EM; Goldsmith D; Simmonds HA; Rutkowski B
Clin Sci (Lond); 2004 Jul; 107(1):69-74. PubMed ID: 14723603
[TBL] [Abstract][Full Text] [Related]
56. [Studies on the adenine nucleotides metabolism in uremic erythrocyte (author's transl)].
Sawada K
Nihon Jinzo Gakkai Shi; 1979 Nov; 21(11):1193-205. PubMed ID: 541880
[No Abstract] [Full Text] [Related]
57. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.
Lee DM; Knight-Gibson C; Samuelsson O; Attman PO; Wang CS; Alaupovic P
Kidney Int; 2002 Jan; 61(1):209-18. PubMed ID: 11786103
[TBL] [Abstract][Full Text] [Related]
58. [The effect of hemodialysis on levels of beta-endorphin in serum of patients with chronic renal failure treated with erythropoietin].
Burak W; Grzeszczak W; Trelewicz P; Zukowska-Szczechowska E
Przegl Lek; 1996; 53(2):54-7. PubMed ID: 8754321
[TBL] [Abstract][Full Text] [Related]
59. Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.
Milionis HJ; Elisaf MS; Karabina SA; Bairaktari E; Tselepis AD; Siamopoulos KC
Kidney Int; 1999 Dec; 56(6):2276-85. PubMed ID: 10594806
[TBL] [Abstract][Full Text] [Related]
60. [Concentration of adenine nucleotides in eryhrocytes and ATPase activity in erythrocyte ghosts during hemoperfusion and hemodialysis in patients with chronic renal failure].
Trznadel K; Kidawa Z; Luciak M; Madry K
Pol Arch Med Wewn; 1978 Sep; 60(3):277-81. PubMed ID: 152433
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
